logo

For the Inventor, By the Inventor

Doylestown, PA, United States of America

Joseph F Gardocki

This inventor holds 13 USPTO granted patents. Top assignees: Mcneil Ab, Mcneil Laboratories, Incorporated. Active years: 1976-1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph F Gardocki. Retrieved from https://idiyas.com/inventor/joseph-f-gardocki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 100.0

Average Co-Inventor Count = 1.2

ph-index = 7

Forward Citations = 216(Granted Patents)


Company Filing History:

goldMedal11 out of 189 
 
Mcneil Ab
 patents
silverMedal2 out of 45 
 
Mcneil Laboratories, Incorporated
 patents

Years Active: 1976-1986

Loading Chart...
13 patents (USPTO):Explore Patents
1. 4582916 - Chlorosulfate and azidosulfate esters of (1986-04-15),
2. 4513006 - Anticonvulsant sulfamate derivatives (1985-04-23),
3. 4338324 - Analgesic potentiation (1982-07-06),
4. 4242353 - Analgesic potentiation (1980-12-30),
5. 4234601 - Analgesic potentiation (1980-11-18),
6. 4233317 - Analgesic potentiation (1980-11-11),
7. 4233316 - Analgesic potentiation (1980-11-11),
8. 4233315 - Analgesic potentiation (1980-11-11),
9. 4233314 - Analgesic potentiation (1980-11-11),
10. 4233313 - Analgesic potentiation (1980-11-11),
11. 4207340 - Analgesic potentiation (1980-06-10),
12. 4046909 - Pyrrolidylidene, piperidylidene and hexahydroazepinylidene ureas as CNS (1977-09-06),
13. 3998958 - Pyrrolidylidene, piperidylidene and hexahydroazepinylidene ureas as CNS (1976-12-21),

Title: Joseph F Gardocki: Innovator in Anticonvulsant Pharmaceuticals

Introduction

Joseph F Gardocki is a notable inventor based in Doylestown, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticonvulsant properties. With a total of 13 patents to his name, Gardocki's work has had a meaningful impact on the treatment of epilepsy and related conditions.

Latest Patents

Among his latest patents are the chlorosulfate and azidosulfate esters of sulfamates, which have been found to exhibit anticonvulsant activity. These compounds, represented by a specific formula, are useful in treating conditions such as epilepsy. Additionally, pharmaceutical compositions containing these compounds, as well as methods for their use and intermediates, form part of his innovative contributions to the field.

Career Highlights

Throughout his career, Gardocki has worked with prominent companies such as McNeil AB and McNeil Laboratories, Incorporated. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in pharmaceutical science.

Collaborations

Gardocki has collaborated with notable colleagues, including Bruce E Maryanoff and Chris R Rasmussen. These partnerships have likely facilitated the exchange of ideas and expertise, further enhancing the quality of his work.

Conclusion

Joseph F Gardocki's contributions to the field of pharmaceuticals, particularly in the area of anticonvulsant compounds, highlight his innovative spirit and dedication to improving medical treatments. His patents and collaborations reflect a commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…